Twist Bioscience's market cap is currently $1.63B. The company's EPS TTM is $0.33; its P/E ratio is ―; Twist Bioscience is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
